Combined intravenous and oral mesna in outpatients treated with ifosfamide Marshall P. GorenLinda M. McKennaThomas L. Goodman ORIGINAL ARTICLE Pages: 371 - 375
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion L. D. NordR. L. StolfiD. S. Martin ORIGINAL ARTICLE Pages: 376 - 384
Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells Laurent PoulainFrançois SichelJean-Yves Le Talaër ORIGINAL ARTICLE Pages: 385 - 390
Urinary stability of carboxycyclophosphamide and carboxyifosfamide, two major metabolites of the anticancer drugs cyclophosphamide and ifosfamide Claire JoquevielVéronique GilardUlf Niemeyer ORIGINAL ARTICLE Pages: 391 - 399
Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines E. H. HermanJ. ZhangV. J. Ferrans ORIGINAL ARTICLE Pages: 400 - 408
Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft C. Bradley HareGertrude B. ElionHenry S. Friedman ORIGINAL ARTICLE Pages: 409 - 414
Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer Vincent A. MillerJames R. RigasMark G. Kris ORIGINAL ARTICLE Pages: 415 - 418
Pharmacokinetics of doxorubicin and epirubicin in mice during chlorpromazine-induced hypothermia L. Lundgren-ErikssonA. CarlssonR. Hultborn ORIGINAL ARTICLE Pages: 419 - 424
A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene Fumihiko NarasakiMikio OkaShigeru Kohno ORIGINAL ARTICLE Pages: 425 - 432
Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein-overexpressing cell lines Yuko HokiAkira FujimoriYves Pommier ORIGINAL ARTICLE Pages: 433 - 438
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicity Steinar AamdalUta BruntschStan B. Kaye CLINICAL TRIAL REPORT Pages: 439 - 443
Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administration P. G. LindnérDennis HeathLarsolof R. Hafström SHORT COMMUNICATION Pages: 444 - 448
Salivary drug monitoring of irinotecan and its active metabolite in cancer patients Toshiaki TakahashiY. FujiwaraMichio Yamakido SHORT COMMUNICATION Pages: 449 - 452
An N-myristoylated protein kinase C-α pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate Philip J. BergmanKaren R. GravittC. A. O’Brian SHORT COMMUNICATION Pages: 453 - 456